0001012975-24-000230.txt : 20240515 0001012975-24-000230.hdr.sgml : 20240515 20240515163246 ACCESSION NUMBER: 0001012975-24-000230 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 EFFECTIVENESS DATE: 20240515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARCH Venture Management, LLC CENTRAL INDEX KEY: 0001274403 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-19358 FILM NUMBER: 24951791 BUSINESS ADDRESS: STREET 1: C/O ARCH VENTURE PARTNERS STREET 2: 8755 W. HIGGINS RD. #1025 CITY: CHICAGO STATE: IL ZIP: 60631 BUSINESS PHONE: 7733806600 MAIL ADDRESS: STREET 1: C/O ARCH VENTURE PARTNERS STREET 2: 8755 W. HIGGINS RD. #1025 CITY: CHICAGO STATE: IL ZIP: 60631 FORMER COMPANY: FORMER CONFORMED NAME: ARCH VENTURE CORP DATE OF NAME CHANGE: 20031224 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001274403 XXXXXXXX 03-31-2024 03-31-2024 ARCH Venture Management, LLC
C/O ARCH VENTURE PARTNERS 8755 W. HIGGINS RD. #1025 CHICAGO IL 60631
13F HOLDINGS REPORT 028-19358 000158196 802-75688 N
Mark McDonnell Managing Director, CFO and CAO 773-380-6600 /s/ Mark McDonnell Chicago IL 05-15-2024 0 8 80276945 false
INFORMATION TABLE 2 ARCH.xml UNITY BIOTECHNOLOGY, INC. COM 91381U200 1647900 1004817 SH SOLE 0 0 1004817 DENALI THERAPEUTICS, INC. COM 24823R105 7823229 381249 SH SOLE 0 0 381249 Q32 BIO INC. COM 746964105 5461013 320482 SH SOLE 0 0 320482 GOSSAMER BIO, INC. COM 38341P102 9505981 8055916 SH SOLE 0 0 8055916 SINGULAR GENOMICS SYSTEMS, INC. COM 82933R100 1953408 3798926 SH SOLE 0 0 3798926 CERO THERAPEUTICS HOLDINGS, INC. CLASS A COM 71902K105 4433989 1444296 SH SOLE 0 0 1444296 ERASCA, INC. COM 29479A108 22774441 11055554 SH SOLE 0 0 11055554 VERVE THERAPEUTICS, INC. COM 92539P101 26676984 2008809 SH SOLE 0 0 2008809